Keyphrases
Autologous Stem Cell Rescue
100%
Myoclonus
100%
Killer Cell Immunoglobulin-like Receptor
100%
Ebola Epidemic
100%
Relapsed or Refractory
100%
Secondary Case
100%
Refractory Neuroblastoma
100%
Chemoimmunotherapy
100%
High-risk Neuroblastoma
100%
Virology
100%
From Bench to Bed
100%
Myeloablative
66%
COVID-19
50%
Virus
50%
Irinotecan
44%
Tandem Transplantation
33%
CD34 Selection
33%
Dinutuximab
33%
CSF-1
33%
Granulocyte Macrophages
33%
Group Setting
33%
Randomized Comparison
33%
Myeloablative Regimen
33%
Tertiary Lymphoid Structures
25%
Human Pathogens
25%
Controversial Issues
25%
Respiratory Infection
25%
Aid Policy
25%
Neurological Impairment
25%
Long History
25%
Vocal
25%
Politicians
25%
Research Conduct
25%
Regulatory Structure
25%
Function Approach
25%
United States
25%
Immunosuppression
25%
COVID-19 Pandemic
25%
Gain-of-function
25%
Evidence-based
25%
Safe Behavior
25%
Public Concern
25%
Disease Burden
25%
First Relapse
22%
Temsirolimus
22%
Anti-GD2 Antibody
22%
Guinea
20%
Negative Binomial Regression
20%
Understanding Risk
20%
Therapy Tool
20%
Complete Cure
20%
Tumor-infiltrating B Cells
12%
Tumor-specific Transcripts
12%
Candidate Autoimmune Genes
12%
Childhood Solid Tumors
12%
Paraneoplastic
12%
Paraneoplastic Syndrome
12%
Class II Alleles
12%
Tumor-infiltrating T Cells
12%
B Cell Infiltration
12%
Severity Score
12%
Correction for multiple Comparison
11%
Surface Marker Expression
11%
Bonferroni Correction
11%
Median Value
11%
Refractory Disease
11%
Neutrophil Count
11%
White Cell Count
11%
Association Test
11%
CD161
11%
CD56
11%
Trial Registration
11%
Medicine and Dentistry
High Dose Chemotherapy
100%
Stem Cell
100%
Ganglioneuroblastoma
100%
Opsoclonus Myoclonus Syndrome
100%
Emergency Medical Technician
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Oncology
100%
Pathogenesis
50%
Immunosuppressive Treatment
50%
COVID-19
50%
Respiratory Tract Infection
50%
Virologist
50%
Disease Burden
50%
Antivirus Agent
50%
Malignant Neoplasm
50%
Peripheral Blood Stem Cell
25%
Transplantation
25%
Viral Disease
25%
Tertiary Lymphoid Structure
22%
Paraneoplastic Syndrome
11%
Immunology and Microbiology
Killer-Cell Immunoglobulin-Like Receptor
100%
Virology
100%
Irinotecan
44%
Severe Acute Respiratory Syndrome Coronavirus 2
40%
Dinutuximab
33%
Immunotherapy
33%
Granulocyte
33%
Macrophage
33%
Leukocyte
22%
Natural Killer Cell
22%
Temsirolimus
22%
Immunosuppression
20%
Vaccine Efficacy
20%
Human Pathogen
20%
COVID-19
20%
Disease Burden
20%
Fc Receptor
11%
Immunocompetent Cell
11%
Cell Subpopulation
11%
Peripheral Blood Mononuclear Cell
11%
Blood Cell Count
11%
Neutrophil Count
11%
NCR3
11%
Paraneoplastic Syndrome
11%
Cell Surface
11%
Leukocyte Count
11%
Blood Flow
11%